{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T08:56:21Z","timestamp":1696928181216},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00228-016-2066-5","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T06:20:43Z","timestamp":1461910843000},"page":"1031-1032","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap"],"prefix":"10.1007","volume":"72","author":[{"given":"Jamil","family":"Poletti-Jabbour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Wiegering-Rospigliosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene\u00e9","family":"Pereyra-El\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Cecilia","family":"El\u00edas-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"issue":"5 Suppl","key":"2066_CR1","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","volume":"25","author":"E Carrazana","year":"2003","unstructured":"Carrazana E, Mikoshiba I (2003) Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manag 25(5 Suppl):S31\u2013S35","journal-title":"J Pain Symptom Manag"},{"key":"2066_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/etm.2015.2549","volume":"10","author":"H Chantaphakul","year":"2015","unstructured":"Chantaphakul H, Sanon T, Klaewsongkram J (2015) Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Ther Med 10:519\u2013524","journal-title":"Exp Ther Med"},{"key":"2066_CR3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","volume":"15","author":"G Cruccua","year":"2008","unstructured":"Cruccua G, Gronsethb G, Alksnec J, Argoffd C, Brainine M, Burchiel K, et al. (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15:1013\u20131028","journal-title":"Eur J Neurol"},{"key":"2066_CR4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, Haanp\u00e4\u00e4 M, Hansson P, Jensen TS, et al. (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113\u20131123","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"2066_CR5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10194-011-0402-9","volume":"13","author":"L Bendtsen","year":"2012","unstructured":"Bendtsen L, Birk S, Kasch H, Aegidius K, S\u00f8rensen PS, Thomsen LL, et al. (2012) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. J Headache Pain 13(Suppl 1):S1\u2013S29","journal-title":"J Headache Pain"},{"key":"2066_CR6","doi-asserted-by":"crossref","unstructured":"Kutluay E, McCague K, D'Souza J, Beydoun A (2003) Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 4:175\u2013180.","DOI":"10.1016\/S1525-5050(03)00037-4"},{"issue":"Suppl 1","key":"2066_CR7","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0165-0327(02)00338-5","volume":"72","author":"JS Hellewell","year":"2002","unstructured":"Hellewell JS (2002) Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. J Affect Disord 72(Suppl 1):S23\u2013S34","journal-title":"J Affect Disord"},{"key":"2066_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","volume":"15","author":"G Stefano Di","year":"2014","unstructured":"Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34","journal-title":"J Headache Pain"},{"key":"2066_CR9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s10194-015-0563-z","volume":"16","author":"E Besi","year":"2015","unstructured":"Besi E, Boniface DR, Cregg R, Zakrzewska JM (2015) Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP). J Headache Pain 16:563","journal-title":"J Headache Pain"},{"key":"2066_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S1516-31802009000300008","volume":"127","author":"H Saconato","year":"2009","unstructured":"Saconato H, Prado GF, Puga ME, Atallah AN (2009) Oxcarbazepine for refractory epilepsy: systematic review of the literature. Sao Paulo Med J 127:150\u2013159","journal-title":"Sao Paulo Med J"},{"key":"2066_CR11","unstructured":"Direcci\u00f3n General de Medicamentos, Insumos y Drogas (2015) Observatorio de productos farmac\u00e9uticos. Lima, DIGEMID."}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2066-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2066-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2066-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T03:56:20Z","timestamp":1567828580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2066-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2066-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}